 So generic drugs, we've talked a lot about them. They seem to be a major piece of this. More than 80% of the shortages occur in that class of drugs. So how do distributors support a more robust and sustainable generics market? Yeah, I think there's a couple of ways that we do that. I think first and foremost is recognizing that the generic industry, and this was touched upon again in the previous discussion, is a significant, overwhelming majority of prescriptions in this country. It's about 90% of all prescriptions and less than 20% of the cost.